Inhalant glucocorticoid application experience among infants with bronchopulmonary dysplasia in the first half year of life
THE ARTICLE DESCRIBES THE MODERN VIEWS ON THE ARRLICATION OF THE INHALANT GLUCOCORTICOIDS (BUDESONIDE SUSRENSION) AMONG INFANTS, WHO UNDERWENT ARTIFICIAL RULMONARY VENTILATION AT THE NEONATAL STAGE AND WHO HAD BRONCHORULMONARY DYSRLASIA FORMED. THE AUTHORS RERFORMED THE CLINICAL AND FUNCTIONAL EVALUATION OF THEIR STATE OWING TO THE BRONCHORHONOGRARHY ALONG WITH THE FOLLOW-UR OBSERVATION UNTIL 6 MONTH OF LIFE.